We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIB icon
4026
Grupo Cibest SA
CIB
$22.7B
$9.54K ﹤0.01%
193
-124
-39% -$6.26K
KEP icon
4027
Korea Electric Power
KEP
$14.8B
$9.53K ﹤0.01%
879
-564
-39% -$6.12K
RMNI icon
4028
Rimini Street
RMNI
$470M
$9.52K ﹤0.01%
2,173
+899
+71% +$4.38K
KRTX
4029
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$9.45K ﹤0.01%
+579
New +$11.3K
GSAT icon
4030
Globalstar
GSAT
$10.7B
$9.35K ﹤0.01%
1,506
VSTM icon
4031
Verastem
VSTM
$604M
$9.33K ﹤0.01%
642
ICD
4032
DELISTED
Independence Contract Drilling, Inc.
ICD
$9.3K ﹤0.01%
387
+4
+1% +$103
PRMW
4033
DELISTED
Primo Water Corporation
PRMW
$9.27K ﹤0.01%
743
IEA
4034
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$9.22K ﹤0.01%
1,978
SUP
4035
DELISTED
Superior Industries International
SUP
$9.16K ﹤0.01%
3,170
-241
-7% -$702
KINS icon
4036
Kingstone Companies
KINS
$282M
$9.13K ﹤0.01%
1,072
QNCX icon
4037
Quince Therapeutics
QNCX
$33M
$9.1K ﹤0.01%
+2
New +$12.3K
XBIT icon
4038
XBiotech
XBIT
$71M
$9.09K ﹤0.01%
869
+778
+855% +$6.34K
DZSI
4039
DELISTED
DZS Inc. Common Stock
DZSI
$9.03K ﹤0.01%
986
+283
+40% +$3.1K
TTOO
4040
DELISTED
T2 Biosystems, Inc
TTOO
$8.99K ﹤0.01%
1
KG
4041
Kestrel Group
KG
$60.5M
$8.98K ﹤0.01%
598
SIMO icon
4042
Silicon Motion
SIMO
$8.45B
$8.91K ﹤0.01%
+252
New +$9.13K
ACMR icon
4043
ACM Research
ACMR
$5.65B
$8.86K ﹤0.01%
1,917
-903
-32% -$4.74K
EVER icon
4044
EverQuote
EVER
$864M
$8.81K ﹤0.01%
413
+391
+1,777% +$7.38K
MGP
4045
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$8.78K ﹤0.01%
292
TRAK icon
4046
ReposiTrak
TRAK
$158M
$8.77K ﹤0.01%
1,519
XELA
4047
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$8.74K ﹤0.01%
+1
New +$20.6K
FONR
4048
DELISTED
Fonar
FONR
$8.68K ﹤0.01%
420
-292
-41% -$6.71K
JNCE
4049
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$8.62K ﹤0.01%
2,589
-5
-0.2% -$20
YARW
4050
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$8.61K ﹤0.01%
1

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.